These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3671896)

  • 21. Two-week nifedipine treatment for pulmonary hypertension complicating chronic obstructive lung disease.
    Saadjian A; Philip-Joet F; Guintoli A; Torresani J; Arnaud A
    Eur J Respir Dis; 1985 Nov; 67(5):346-50. PubMed ID: 4085586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic effects of nifedipine in pulmonary hypertension.
    Klugmann S; Salvi A; Fioretti P; Camerini F
    G Ital Cardiol; 1982; 12(7):505-8. PubMed ID: 7169146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of a shared mechanism of vasoconstriction in pulmonary and systemic circulation in hypertension: a possible role of intracellular calcium.
    Guazzi MD; Polese A; Bartorelli A; Loaldi A; Fiorentini C
    Circulation; 1982 Oct; 66(4):881-6. PubMed ID: 7116604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of dopamine and nifedipine infusions on the pulmonary circulation of the lamb.
    Feltes TF; Fike CD; Hansen TN
    Pediatr Pharmacol (New York); 1986; 5(4):261-71. PubMed ID: 3737271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nifedipine inhibits the effects of almitrine in patients suffering from pulmonary artery hypertension secondary to chronic obstructive pulmonary disease.
    Saadjian A; Philip-Joët F; Barret A; Levy S; Arnaud A
    J Cardiovasc Pharmacol; 1993 May; 21(5):797-803. PubMed ID: 7685452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
    Ziegler JW; Ivy DD; Wiggins JW; Kinsella JP; Clarke WR; Abman SH
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute effects on pulmonary haemodynamics of nifedipine in adult patients with cystic fibrosis.
    Eichler I; Burghuber OC; Götz M
    Eur J Clin Pharmacol; 1990; 39(6):587-8. PubMed ID: 2095344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Miller AB; Conetta DA; Bass TA
    Am J Cardiol; 1985 May; 55(11):1359-62. PubMed ID: 3993570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertension.
    Fisher J; Borer JS; Moses JW; Goldberg HL; Niarchos AP; Whitman HH; Mermelstein M
    Am J Cardiol; 1984 Sep; 54(6):646-50. PubMed ID: 6475787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease.
    Agustí AG; Barberá JA; Roca J; Wagner PD; Guitart R; Rodriguez-Roisín R
    Chest; 1990 Feb; 97(2):268-75. PubMed ID: 2298050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of almitrine bismesylate on pulmonary vasoreactivity to hypoxia in chronic obstructive pulmonary disease.
    Saadjian AY; Philip-Jöel FF; Barret A; Levy S; Arnaud AG
    Eur Respir J; 1994 May; 7(5):862-8. PubMed ID: 8050541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nifedipine in the treatment of chronic cor pulmonale].
    Saadjian A; Philip-Joet F; Tran N'guyen A; Arnaud A; Torresani J
    Arch Mal Coeur Vaiss; 1986 Jan; 79(1):76-83. PubMed ID: 3085613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydralazine does not inhibit canine hypoxic pulmonary vasoconstriction.
    Bishop MJ; Kennard S; Artman LD; Cheney FW
    Am Rev Respir Dis; 1983 Dec; 128(6):998-1001. PubMed ID: 6650991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-induced pulmonary hypertension: nifedipine only temporarily reduces pulmonary artery pressure and vascular tone.
    Agostoni P; Doria E; Fiorentini C; Galli C; Tamborini G; Guazzi M
    Ann Ital Med Int; 1989; 4(3):181-3. PubMed ID: 2702029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with cystic fibrosis and cor pulmonale.
    Michael JR; Kennedy TP; Fitzpatrick S; Rosenstein BJ
    Am Rev Respir Dis; 1984 Sep; 130(3):516-9. PubMed ID: 6476600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of hypoxic pulmonary vasoconstriction by low dose almitrine bismesylate in normal humans.
    Mélot C; Dechamps P; Hallemans R; Decroly P; Mols P
    Am Rev Respir Dis; 1989 Jan; 139(1):111-9. PubMed ID: 2912330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nifedipine inhibits pulmonary hypertension but does not prevent decreased lung eNOS in hypoxic newborn pigs.
    Fike CD; Kaplowitz MR
    Am J Physiol; 1999 Sep; 277(3):L449-56. PubMed ID: 10484451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of nifedipine on diffusing capacity and pulmonary capillary blood volume in chronic obstructive pulmonary disease. A controlled study.
    Dujić Z; Tocilj J; Slavković V
    Respiration; 1991; 58(3-4):186-91. PubMed ID: 1745853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxic pulmonary hypertension: haemodynamic changes after oxygen and various vasodilators in the same patient at different time periods.
    Král H; Hamet A; Cernohorský D; Stásek J; Tilser P
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(4-5):317-24. PubMed ID: 8599074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deleterious effect of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease.
    Melot C; Hallemans R; Naeije R; Mols P; Lejeune P
    Am Rev Respir Dis; 1984 Oct; 130(4):612-6. PubMed ID: 6091508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.